| |
| |
|
| Insider
Information: |
Xanthopoulos Kleanthis G |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
122,200 |
|
|
Indirect Shares
|
281,935 |
|
|
| Direct
Value |
$19,881 |
|
|
|
Indirect Value
|
$170,264 |
|
|
| Total
Shares |
404,135 |
|
|
| Total
Value |
$190,145 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2007-08-16 |
7,399 |
2007-08-16 |
177,144 |
Premium* |
|
|
Seelos Therapeutics Inc |
SEEL |
Director |
2012-08-15 |
87,500 |
2017-01-05 |
24,575 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
President and CEO, Dir... |
2015-04-21 |
3,705 |
2015-04-21 |
80,216 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
Director |
2021-06-10 |
23,596 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZSAN |
Zosano Pharma Corp |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
23,596 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
15,000 |
24,575 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.34 |
$5,750 |
I/I |
16,997 |
95,746 |
0 |
- |
|
| ZSAN |
Zosano Pharma Corp |
Director |
– • – |
2016-08-19 |
4 |
B |
$1.32 |
$21,014 |
D/D |
15,920 |
21,920 |
2.39 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2016-06-30 |
4 |
A |
$0.40 |
$5,750 |
I/I |
14,393 |
78,749 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2016-04-05 |
4 |
A |
$0.58 |
$5,000 |
I/I |
8,621 |
64,356 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-04-21 |
4 |
AS |
$17.73 |
$1,063,980 |
D/D |
(60,000) |
3,705 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-04-21 |
4 |
OE |
$0.38 |
$22,800 |
D/D |
60,000 |
63,705 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-04-20 |
4 |
OE |
$0.38 |
$25,107 |
D/D |
66,071 |
69,776 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-04-20 |
4 |
AS |
$16.85 |
$1,113,514 |
D/D |
(66,071) |
3,705 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-04-17 |
4 |
AS |
$16.94 |
$1,252,002 |
D/D |
(73,929) |
3,705 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-04-17 |
4 |
OE |
$0.38 |
$28,093 |
D/D |
73,929 |
77,634 |
0 |
- |
|
| ZSAN |
Zosano Pharma Corp |
Director |
– • – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-03-05 |
4 |
AS |
$20.06 |
$1,808,063 |
D/D |
(89,230) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-03-05 |
4 |
OE |
$0.38 |
$33,907 |
D/D |
89,230 |
91,696 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-02-27 |
4 |
AS |
$19.50 |
$1,365 |
D/D |
(70) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-02-27 |
4 |
OE |
$0.38 |
$27 |
D/D |
70 |
2,536 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-02-02 |
4 |
AS |
$19.77 |
$47,440 |
D/D |
(2,400) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-02-02 |
4 |
OE |
$0.38 |
$912 |
D/D |
2,400 |
4,866 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-01-30 |
4 |
AS |
$19.50 |
$64,351 |
D/D |
(3,300) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-01-30 |
4 |
OE |
$0.38 |
$1,254 |
D/D |
3,300 |
5,766 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-01-29 |
4 |
AS |
$17.77 |
$1,082,634 |
D/D |
(60,000) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-01-29 |
4 |
OE |
$0.38 |
$22,800 |
D/D |
60,000 |
62,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-01-28 |
4 |
AS |
$17.97 |
$1,536,515 |
D/D |
(85,000) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-01-28 |
4 |
OE |
$0.38 |
$32,300 |
D/D |
85,000 |
87,466 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
